Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agents

Sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agents

US Patent 8507510 · Granted Aug 13, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 5-fluoro-1H-pyrazolopyridines and their use2024
Inhibitor of ATR kinase for use in a method of treating a hyper-proliferative di2024
Predictive markers for ATR kinase inhibitors2023
PTEFB inhibiting macrocyclic compounds2023
Combination of ATR kinase inhibitors with PARP inhibitors2023
2-(morpholin-4-yl)-1,7-naphthyridines2022
2-(morpholin-4-yl)-1,7-naphthyridines2022
Substituted 5-fluoro-1H-pyrazolopyridines and their use2022
PTEFb inhibiting macrocyclic compounds2022
PTEFb inhibiting macrocyclic compounds2022
2-(morpholin-4-yl)-1,7-naphthyridines2020
2-(morpholin-4-yl)-1,7-naphthyridines2020